Home › Epilepsy › New Jersey
Epilepsy clinical trials in New Jersey
5 studies for Epilepsy are looking for participants at sites in New Jersey.
Cities in New Jersey
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Northeast Regional Epilepsy Group, Hackensack
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07563881AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
- Northeast Regional Epilepsy Group, Hackensack
- Robert Wood Johnson Hospital, New Brunswick
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Aug 24, 2026 · NCT06063850A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
- NEREG, Hackensack
- Inst of Neurology, Livingston
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Aug 24, 2026 · NCT06132893A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Northeast Regional Epilepsy Group, Hackensack
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 10, 2026 · NCT05667142A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Northeast Regional Epilepsy Group, Hackensack
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT05716100From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.